• Altria Group, Inc. reported past first-quarter 2026 results with sales of US$4,758 million and net income of US$2.18 billion, more than double the prior year’s figure, alongside basic and diluted EPS from continuing operations of US$1.30.
• Beyond the headline earnings, the nationwide rollout of Altria’s on! PLUS nicotine pouches to about 100,000 stores highlights how its oral segment is becoming a more prominent earnings contributor.
• We’ll now examine how this strong quarter, especially the growth in oral nicotine pouches, may influence Altria’s existing investment narrative.

The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

Altria Group Investment Narrative Recap

To own Altria, you generally have to believe its high-margin cigarette franchise can fund a gradual pivot toward smoke-free products while supporting generous cash returns. The latest quarter, with higher earnings and rapid expansion of on! PLUS nicotine pouches, reinforces that near term catalyst. The biggest current risk remains regulatory and legal pressure, including ongoing Juul related litigation and uncertainty around how regulators will treat both authorized and illicit nicotine products.

The most relevant recent announcement here is the nationwide rollout of on! PLUS, which reached about 100,000 stores by the end of Q1 2026. That scale matters if you see growth in oral nicotine as offsetting pressure in traditional cigarettes and soft earnings trends over the past year, but it sits alongside questions about high debt, significant one off items and whether cash flows can keep comfortably funding dividends and buybacks.

Yet beneath the strong quarter, one risk investors should be aware of is how ongoing Juul litigation and regulatory scrutiny could suddenly reshape...

Altria Group's narrative projects $20.3 billion revenue and $9.5 billion earnings by 2029. This assumes revenue remains flat each year and requires an earnings increase of about $2.6 billion from $6.9 billion today.

Uncover how Altria Group's forecasts yield a $65.50 fair value, a 5% downside to its current price.

Exploring Other Perspectives

Some of the lowest ranked analysts paint a much darker picture, assuming roughly flat revenues near US$19.8 billion and only about US$9.1 billion in earnings by 2029, and if you worry about illicit e vapor undercutting NJOY and on! just as this strong quarter lands, it is a reminder that reasonable people can see the same data very differently and you should compare several viewpoints before deciding what you believe.

Explore 8 other fair value estimates on Altria Group - why the stock might be worth as much as 84% more than the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Altria Group research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Altria Group research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Altria Group's overall financial health at a glance.

Seeking Other Investments?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• Uncover the next big thing with 26 elite penny stocks that balance risk and reward.
• We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.